Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention

Abstract Objective: To investigate the clinical significance of serum cystatin C (Cys-C) and high-sensitivity C-reactive protein (hs-CRP) in coronary heart disease (CHD) patients undergoing percutaneous coronary intervention (PCI). Methods: One hundred and twenty-eight CHD patients were divided in...

Full description

Bibliographic Details
Main Authors: Zheng Tan, Li Li, Yi Ma, Xuebin Geng
Format: Article
Language:English
Published: Sociedade Brasileira de Cirurgia Cardiovascular
Series:Brazilian Journal of Cardiovascular Surgery
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000100017&lng=en&tlng=en
id doaj-dc42ad0e3a1f4b6ea4b8cc296021a107
record_format Article
spelling doaj-dc42ad0e3a1f4b6ea4b8cc296021a1072020-11-25T01:00:23ZengSociedade Brasileira de Cirurgia CardiovascularBrazilian Journal of Cardiovascular Surgery1678-9741341172110.21470/1678-9741-2018-0171S0102-76382019000100017Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary InterventionZheng TanLi LiYi MaXuebin GengAbstract Objective: To investigate the clinical significance of serum cystatin C (Cys-C) and high-sensitivity C-reactive protein (hs-CRP) in coronary heart disease (CHD) patients undergoing percutaneous coronary intervention (PCI). Methods: One hundred and twenty-eight CHD patients were divided into drug treatment (56 cases) and PCI treatment (72 cases) groups, receiving conventional drug treatment and PCI plus conventional drug treatment, respectively. At admission time and 4 weeks after treatment, the left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter, and left ventricular end systolic diameter were measured. At admission time and 24h, 72h, 1 week, and 4 weeks after treatment, the serum levels of Cys-C and hs-CRP were determined. Results: After 4 weeks of treatment, LVEF in the PCI treatment group was significantly higher than that before treatment (P<0.01) and it was significantly higher than in the drug treatment group at the same time (P<0.01). Cys-C and hs-CRP level in the PCI treatment group were significantly higher than in the drug treatment group 72h and 1 week after treatment (P<0.05 or P<0.01), respectively, but they were significantly lower than in the drug treatment group 4 weeks after treatment (P<0.01). There were obvious interaction effects between grouping factor and time factor in Cys-C (F=3.62, P<0.05) and hs-CRP (F=17.85, P<0.01). Conclusion: Serum levels of Cys-C and hs-CRP are closely related to the heart function in CHD patients undergoing PCI, and they may be used for predicting the outcome of PCI.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000100017&lng=en&tlng=enCoronary DiseasePercutaneous Coronary InterventionCystatin CC-Reactive Protein
collection DOAJ
language English
format Article
sources DOAJ
author Zheng Tan
Li Li
Yi Ma
Xuebin Geng
spellingShingle Zheng Tan
Li Li
Yi Ma
Xuebin Geng
Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
Brazilian Journal of Cardiovascular Surgery
Coronary Disease
Percutaneous Coronary Intervention
Cystatin C
C-Reactive Protein
author_facet Zheng Tan
Li Li
Yi Ma
Xuebin Geng
author_sort Zheng Tan
title Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
title_short Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
title_full Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
title_fullStr Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
title_full_unstemmed Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention
title_sort clinical significance of cys-c and hs-crp in coronary heart disease patients undergoing percutaneous coronary intervention
publisher Sociedade Brasileira de Cirurgia Cardiovascular
series Brazilian Journal of Cardiovascular Surgery
issn 1678-9741
description Abstract Objective: To investigate the clinical significance of serum cystatin C (Cys-C) and high-sensitivity C-reactive protein (hs-CRP) in coronary heart disease (CHD) patients undergoing percutaneous coronary intervention (PCI). Methods: One hundred and twenty-eight CHD patients were divided into drug treatment (56 cases) and PCI treatment (72 cases) groups, receiving conventional drug treatment and PCI plus conventional drug treatment, respectively. At admission time and 4 weeks after treatment, the left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter, and left ventricular end systolic diameter were measured. At admission time and 24h, 72h, 1 week, and 4 weeks after treatment, the serum levels of Cys-C and hs-CRP were determined. Results: After 4 weeks of treatment, LVEF in the PCI treatment group was significantly higher than that before treatment (P<0.01) and it was significantly higher than in the drug treatment group at the same time (P<0.01). Cys-C and hs-CRP level in the PCI treatment group were significantly higher than in the drug treatment group 72h and 1 week after treatment (P<0.05 or P<0.01), respectively, but they were significantly lower than in the drug treatment group 4 weeks after treatment (P<0.01). There were obvious interaction effects between grouping factor and time factor in Cys-C (F=3.62, P<0.05) and hs-CRP (F=17.85, P<0.01). Conclusion: Serum levels of Cys-C and hs-CRP are closely related to the heart function in CHD patients undergoing PCI, and they may be used for predicting the outcome of PCI.
topic Coronary Disease
Percutaneous Coronary Intervention
Cystatin C
C-Reactive Protein
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000100017&lng=en&tlng=en
work_keys_str_mv AT zhengtan clinicalsignificanceofcyscandhscrpincoronaryheartdiseasepatientsundergoingpercutaneouscoronaryintervention
AT lili clinicalsignificanceofcyscandhscrpincoronaryheartdiseasepatientsundergoingpercutaneouscoronaryintervention
AT yima clinicalsignificanceofcyscandhscrpincoronaryheartdiseasepatientsundergoingpercutaneouscoronaryintervention
AT xuebingeng clinicalsignificanceofcyscandhscrpincoronaryheartdiseasepatientsundergoingpercutaneouscoronaryintervention
_version_ 1725213725372186624